dockets: FDA-1977-N-0013

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-1977-N-0013 FDA Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN Nonrulemaking 2019-02-05T07:41:47Z 0b000064805d7f3b   Docket Status: OPEN     ["NSAIDS", "Acetaminophen Hepatotoxicity", "Risk Factor", "Allergy Alert", "ANTIPYRETIC", "INTERNAL ANALGESIC", "Required Warnings", "ALCOHOL", "ASPIRIN", "INTERNAL", "OTC", "ANTIPYRETIC", "ACETAMINOPHEN", "SYMPTOMS", "OVERDOSE", "ANTIRHEUMATIC", "PRODUCTS", "ANALGESIC", "CDER", "OPEN"] CDER Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment ot the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "legacyId", "label": "Legacy ID", "tooltip": "A pre-FDMS agency specific identifier migrated from a legacy system."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["NSAIDS", "Acetaminophen Hepatotoxicity", "Risk Factor", "Allergy Alert", "ANTIPYRETIC", "INTERNAL ANALGESIC", "Required Warnings", "ALCOHOL", "ASPIRIN", "INTERNAL", "OTC", "ANTIPYRETIC", "ACETAMINOPHEN", "SYMPTOMS", "OVERDOSE", "ANTIRHEUMATIC", "PRODUCTS", "ANALGESIC", "CDER", "OPEN"], "modifyDate": "2019-02-05T07:41:47Z", "dkAbstract": "Docket Status: OPEN", "agencyId": "FDA", "program": "CDER", "shortTitle": "Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment ot the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN", "subType2": null, "title": "Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling - OPEN", "generic": "N", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": "1977N-0094L", "subType": null, "category": null, "field2": "OPEN", "effectiveDate": null, "objectId": "0b000064805d7f3b"} single_get

Links from other tables